ATE155343T1 - Verwendung von 2-(4-(-chlorophenyl)cyclohexyl>-3- hydroxy-1,4-naphtoquinon zur behandlung von krebs - Google Patents

Verwendung von 2-(4-(-chlorophenyl)cyclohexyl>-3- hydroxy-1,4-naphtoquinon zur behandlung von krebs

Info

Publication number
ATE155343T1
ATE155343T1 AT94906748T AT94906748T ATE155343T1 AT E155343 T1 ATE155343 T1 AT E155343T1 AT 94906748 T AT94906748 T AT 94906748T AT 94906748 T AT94906748 T AT 94906748T AT E155343 T1 ATE155343 T1 AT E155343T1
Authority
AT
Austria
Prior art keywords
treatment
pct
tumours
chlorophenyl
cyclohexyl
Prior art date
Application number
AT94906748T
Other languages
English (en)
Inventor
Alan Thomas Hudson
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Application granted granted Critical
Publication of ATE155343T1 publication Critical patent/ATE155343T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT94906748T 1992-08-07 1993-08-06 Verwendung von 2-(4-(-chlorophenyl)cyclohexyl>-3- hydroxy-1,4-naphtoquinon zur behandlung von krebs ATE155343T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929216859A GB9216859D0 (en) 1992-08-07 1992-08-07 Medicaments

Publications (1)

Publication Number Publication Date
ATE155343T1 true ATE155343T1 (de) 1997-08-15

Family

ID=10720039

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94906748T ATE155343T1 (de) 1992-08-07 1993-08-06 Verwendung von 2-(4-(-chlorophenyl)cyclohexyl>-3- hydroxy-1,4-naphtoquinon zur behandlung von krebs

Country Status (11)

Country Link
US (1) US5567738A (de)
EP (1) EP0653936B1 (de)
JP (1) JPH07509710A (de)
KR (1) KR950702413A (de)
AT (1) ATE155343T1 (de)
AU (1) AU676687B2 (de)
CA (1) CA2141274A1 (de)
DE (1) DE69312297T2 (de)
ES (1) ES2105643T3 (de)
GB (1) GB9216859D0 (de)
WO (1) WO1994003163A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5883270A (en) * 1996-02-20 1999-03-16 Wisconsin Alumni Research Foundation 4-substituted-1, 2-naphthoquinones and their use in the inhibition of neoplastic cell growth
WO2001051089A1 (de) * 2000-01-13 2001-07-19 Merck Patent Gmbh Pharmazeutische zubereitungen enthaltend 2-pyrrolidon als lösungsvermittler
WO2012153162A1 (en) 2011-05-12 2012-11-15 Lupin Limited Novel method for preparation of atovaquone
WO2013014486A1 (en) 2011-07-28 2013-01-31 Lupin Limited Improved synthesis of 2-(4-(4-chlorophenyl) cyclohex-1-enyl) -3, 4-dihydronaphthalen-1 (2h)-one; an intermediate for atovaquone
KR101990054B1 (ko) * 2017-04-25 2019-06-17 대구대학교 산학협력단 로손을 유효성분으로 포함하는 항암 조성물

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2533648A (en) * 1949-03-05 1950-12-12 Joseph H Warburg Circular saw making
US3347742A (en) * 1965-05-28 1967-10-17 Merck & Co Inc 2-(4-cyclohexylcyclohexyl)-3-hydroxy-1, 4-naphthoquinone in controlling coccidiosis in poultry
US3367830A (en) * 1965-06-23 1968-02-06 Merck & Co Inc Controlling coccidiosis in poultry with 1,4-naphthoquinones
GB1141735A (en) * 1966-11-23 1969-01-29 Pfizer & Co C Pharmaceutical anti-tumor composition
US3655699A (en) * 1970-03-02 1972-04-11 Pfizer Analogues of lapachol as antitumor agents
GB1553424A (en) * 1976-02-10 1979-09-26 Wellcome Found Method of treating protozal diseases
PT68813A (en) * 1977-11-22 1978-12-01 Wellcome Found Anti-theilerial naphthoquinones
US4485117A (en) * 1981-10-16 1984-11-27 Hudson Alan T Antiprotozoal compounds
US4485116A (en) * 1981-10-16 1984-11-27 Hudson Alan T Antiprotozoal compounds
GB8310140D0 (en) * 1983-04-14 1983-05-18 Wellcome Found Antiprotozoal agents
GB8310141D0 (en) * 1983-04-14 1983-05-18 Wellcome Found Naphthoquinone derivatives
US5053432A (en) * 1983-04-14 1991-10-01 Burroughs Wellcome Co. Naphthoquinone derivatives
GB8819477D0 (en) * 1988-08-16 1988-09-21 Wellcome Found Medicaments
US5206268A (en) * 1988-08-16 1993-04-27 Burroughs Wellcome Co. Medicaments
ES2052012T3 (es) * 1988-08-16 1994-07-01 Wellcome Found Naftoquinonas para el tratamiento y profilaxis de infecciones por pneumocystis carinii.
DE68912262T2 (de) * 1988-10-07 1994-05-11 Sakai Chemical Industry Co Katalysatoren und Verfahren zur Denitrierung.

Also Published As

Publication number Publication date
DE69312297D1 (de) 1997-08-21
AU676687B2 (en) 1997-03-20
JPH07509710A (ja) 1995-10-26
EP0653936A1 (de) 1995-05-24
ES2105643T3 (es) 1997-10-16
DE69312297T2 (de) 1997-10-30
EP0653936B1 (de) 1997-07-16
KR950702413A (ko) 1995-07-29
CA2141274A1 (en) 1994-02-17
WO1994003163A1 (en) 1994-02-17
AU4722493A (en) 1994-03-03
US5567738A (en) 1996-10-22
GB9216859D0 (en) 1992-09-23

Similar Documents

Publication Publication Date Title
FI971951A0 (fi) 2,2-dikloroalkaanikarboksyylihapot, menetelmät niiden valmistamiseksi, niitä sisältävät lääkkeet, ja niiden käyttö insuliiniresistanssin hoitoon
CY1105545T1 (el) Θεραπεια στατινης για ενισχυση της διατηρησης νοητικης λειτουργιας
ATE155343T1 (de) Verwendung von 2-(4-(-chlorophenyl)cyclohexyl>-3- hydroxy-1,4-naphtoquinon zur behandlung von krebs
DE69516110T2 (de) Verwendung von riluzol zur behandlung mitochondrialer erkrankungen
ATE190484T1 (de) Arzneimittel zur behandlung von durch babesia verursachten protozoeninfektionen
DE68916651T2 (de) Heilmittel zur behandlung von toxoplasmose.
FI950403A0 (fi) Neurosuojaavia yhdisteitä
DE68916443D1 (de) Arzneimittel zur behandlung von kryptosporidiose.
GEP19970834B (en) 2-(4-(4-chlorophenyl)cyclohexyl)-3-hydroxy-1,4-naphthoquinone
DE69421705D1 (de) Verwendung von Efaroxan und dessen Derivaten zur Herstellung eines Arzneimittels zur Behandlung neurogenerativer Erkrankungen
DE60113895D1 (de) Verwendung von Tiludronsäure beim Geflügel zur Herstellung eines Arzneimittels zur Prophylaxe und Behandlung von Osteoporose

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties